scenery, at this stage its still fetus stage just 4 months after the conception. Soon the baby should be ready for delivery. But as the fetus is growing and its features becoming more defined, the underlying value of the share price should be increasing accordingly.
Actually for those looking for a cheaper entry, should buy Titijaya-PA. It's a very interesting play. At current price, you won't lose at all but stand to gain a lot if price go above 0.80. You have 2 options of conversion, 1) convert at 10:1 ratio, 2) convert with paying 0.745 for 1:1 conversion. On top of that there is dividend gain too.
wallstreetrookie looks like you are holding lots of paper lost in glove related counters. Please don't come here to create fear. Tomoro you should sell your LKL and buy TRSB to recover your losses, and you can thank me later :)
*Malaysia to become the hub of manufacturing Covid-19 vaccine for countries in the Asean region *TRSB providing medical real estate recommended by Sinopharm Group or SMEQ pertaining to the New Business. *Under the Agreement, TRSB is not be involved in any production of gloves, personal protection equipment and medical products.
so, very obvious what is the "medical real estate" for ..... looks like something is brewing.....
@salman likely the "Purpose-built Medical Base" is vaccine hub.
why build a factory here to produce ppe, gloves and others since there is already agreement with Rubberex for the import and export, doesnt make sense, right?
there are 2 types of vaccines from sinopharm under phase 3 trials
"In Phase 3 trials in the United Arab Emirates, 5,000 people are receiving the Wuhan Institute version, while another 5,000 are receiving the Beijing Institute one."
Menort, yes those companies above are profit making but their share prices have gone up so many times and have become so risky to buy at current levels
Titijaya also selling gloves too and its share price yet to reflect its potential earnings from its business diversification
Moreover, Titijaya has 5 years contract to sell Sinopharm medical products so once Sinopharm covid19 vaccine receives final approval, Titijaya potential earnings will have quantum leap and share price may limit up many many times
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Friendship
1,616 posts
Posted by Friendship > 2020-08-16 22:40 | Report Abuse
Titijaya once profit taking over then should trend up again soon